Over the past century we have become adept at suppressing the symptoms of respiratory diseases but we have made little progress in curing them. Respiratory diseases are responsible for over 650,000 deaths annually in the EU and the burden on health systems is increasing as the population ages. A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases. All stakeholders in respiratory medicine are pooling their knowledge and resources to focus on risk factors to find cures, formulate new vaccines and develop cutting-edge technologies to tackle the burden of chronic respiratory diseases.
European Respiratory Society: A revolutionary collaborative approach to research funding is providing new insights into the origins of chronic respiratory diseases.
Share this post
Latest News posts
Vaccine Types
November 22, 2021
Vitamin D supplements
November 3, 2021
Herd immunity to COVID-19 – is it achievable?
October 28, 2021
Walk and paint yourself back to health & wellbeing
October 14, 2021
Antifungal Drug Pipeline
October 8, 2021
Is it COVID or just a cold?
September 24, 2021
World Sepsis Day 2021
September 13, 2021
Aspergillosis and Depression: A Personal Reflection
September 1, 2021
Therapeutic drug monitoring (TDM)
August 9, 2021
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video